US food giant General Mills has entered into a licence agreement with Martek Biosciences for a patented technology designed to better preserve food.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The deal with Martek, maker of the DHA brand, will see the use of microencapsulation technology in General Mills’ foods – a process that protects the integrity of food ingredients and helps maintain the nutritional value, shelf-life and flavour of the product.
Developed by General Mills, the technology is expected to enhance Martek’s ability to produce ‘high-quality’, cost-effective DHA powders for certain food applications, particularly long-shelf life products and applications with sensory and formulation challenges.
Under the terms of the agreement, Martek is granted an exclusive licence, with respect to third parties, to the General Mills technology for use with DHA and other polyunsaturated fatty acids. General Mills retains the right to this technology for its own use and exclusively for all uses within some of its core businesses.
“Through this technology, we look forward to providing the important health benefits of DHA to even more consumers around the world through healthy, convenient and high-quality products in a broad range of categories,” said David Abramson, Martek president.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData
